In This Article:
The U.S. stock market has shown resilience, with the Dow Jones Industrial Average rising on a softer-than-expected Producer Price Index report and a dip in oil prices. For those interested in exploring smaller or newer companies, penny stocks—despite their somewhat outdated name—remain an intriguing investment area. These stocks can offer a mix of affordability and growth potential, especially when backed by strong financials, making them appealing to investors seeking under-the-radar opportunities.
Top 10 Penny Stocks In The United States
| Name | Share Price | Market Cap | Financial Health Rating |
| Inter & Co (NasdaqGS:INTR) | $4.33 | $1.87B | ★★★★☆☆ |
| QuantaSing Group (NasdaqGM:QSG) | $3.08 | $100.69M | ★★★★★★ |
| BAB (OTCPK:BABB) | $0.87 | $6.14M | ★★★★★★ |
| Kiora Pharmaceuticals (NasdaqCM:KPRX) | $3.41 | $10.57M | ★★★★★★ |
| ZTEST Electronics (OTCPK:ZTST.F) | $0.3175 | $12.14M | ★★★★★★ |
| Golden Growers Cooperative (OTCPK:GGRO.U) | $4.50 | $67.38M | ★★★★★★ |
| BTCS (NasdaqCM:BTCS) | $2.37 | $44.07M | ★★★★★★ |
| Smith Micro Software (NasdaqCM:SMSI) | $1.23 | $24.12M | ★★★★★☆ |
| CBAK Energy Technology (NasdaqCM:CBAT) | $0.9234 | $86.33M | ★★★★★☆ |
| Safe Bulkers (NYSE:SB) | $3.55 | $377.99M | ★★★★☆☆ |
Click here to see the full list of 720 stocks from our US Penny Stocks screener.
Let's take a closer look at a couple of our picks from the screened companies.
Toro
Simply Wall St Financial Health Rating: ★★★★★★
Overview: Toro Corp. is a shipping company that acquires, owns, charters, and operates oceangoing tanker vessels to provide seaborne transportation services for crude oil, LPG, and refined petroleum products globally, with a market cap of $53.33 million.
Operations: The company's revenue is derived from its LPG Carrier Segment, which generates $15.25 million, and its Handysize Tanker Segment, contributing $9.21 million.
Market Cap: $53.33M
Toro Corp., a shipping company with a market cap of US$53.33 million, has shown significant growth in earnings, rising by 451.7% over the past year, surpassing industry averages. Despite this growth, recent earnings reports indicate a decline in net income to US$24.23 million from US$112.41 million the previous year, and sales fell to US$5.46 million from US$11.86 million. Toro boasts an outstanding return on equity at 44.8% and maintains financial stability with no debt and short-term assets of $195.2M exceeding liabilities of $5.3M, although its management team is relatively inexperienced.
-
Dive into the specifics of Toro here with our thorough balance sheet health report.
-
Understand Toro's track record by examining our performance history report.
Veru
Simply Wall St Financial Health Rating: ★★★★★☆
Overview: Veru Inc. is a late clinical stage biopharmaceutical company that develops medicines for metabolic diseases, oncology, and viral-induced acute respiratory distress syndrome (ARDS), with a market cap of $114.44 million.